-+ 0.00%
-+ 0.00%
-+ 0.00%

Foghorn Therapeutics announces annual shareholder meeting via webcast

PUBT·04/30/2026 11:01:46
Listen to the news
Foghorn Therapeutics announces annual shareholder meeting via webcast
  • Foghorn Therapeutics schedules virtual annual stockholder meeting for June 24, 2026.
  • Ballot includes election of three Class III directors: Douglas Cole, Balkrishan (Simba) Gill, B. Lynne Parshall.
  • Shareholders to vote on ratification of Deloitte & Touche as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Advisory vote set on named executive officer pay.
  • Separate advisory vote set on preferred frequency of future executive pay votes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Foghorn Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-193928), on April 30, 2026, and is solely responsible for the information contained therein.